期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
Destabilization of acrosome and elastase influence mediate the release of secretory phospholipase A2 from human spermatozoa 被引量:2
1
作者 Jacqueline Leβig Uta Reibetanz +1 位作者 Jiirgen Arnhold Hans-Jtirgen Glander 《Asian Journal of Andrology》 SCIE CAS CSCD 2008年第6期829-836,共8页
Aim: To determine the cellular distribution of secretory phospholipase A2 (sPLA2) in dependence on the acrosomal state and under the action of elastase released under inflammatory processes from leukocytes. Methods... Aim: To determine the cellular distribution of secretory phospholipase A2 (sPLA2) in dependence on the acrosomal state and under the action of elastase released under inflammatory processes from leukocytes. Methods: Acrosome reaction of spermatozoa was triggered by calcimycin. Human leukocyte elastase was used to simulate inflammatory conditions. To visualize the distribution of sPLA2 and to determine the acrosomal state, immunofluorescence techniques and lectin binding combined with confocal laser scanning fluorescence microscopy and flow cytometry were used. Results: Although sPLA2 was detected at the acrosome and tail regions in intact spermatozoa, it disappeared from the head region after triggering the acrosome reaction. This release of sPLA2 was associated with enhanced binding of annexin V-fluoroscein isothiocyanate (FITC) to spermatozoa surfaces, intercalation of ethidium-homodimer I, and binding of FITC-labelled concanavalin A at the acrosomal region. Spermatozoa from healthy subjects treated with elastase were characterized by release of sPLA2, disturbance of acrosome structure, and loss of vitality. Conclusion: The ability of spermatozoa to release secretory phospholipase A2 is related to the acrosomal state. Premature destabi- lization of the acrosome and loss of sPLA2 can occur during silent inflammations in the male genital tract. The distribution pattern of sPLA2 in intact spermatozoa might be an additional parameter for evaluating sperm quality. 展开更多
关键词 acrosome reaction ELASTASE human spermatozoa INFLAMMATION secretory phospholipase a2
下载PDF
高血压前期患者的代谢状态及高敏C反应蛋白、分泌型磷脂酶A_2的关系 被引量:9
2
作者 何德化 万晓群 《中国循证心血管医学杂志》 2012年第5期468-470,共3页
目的探讨高血压前期患者的代谢状态及高敏C反应蛋白(hs-CRP)和分泌型磷脂酶A2(sPLA2)的关系。方法纳入300例体检部及心血管内科门诊初诊者,按照血压水平分为正常血压组(n=81)、高血压前期组(n=153)和高血压组(n=66),分别检测炎症指标sP... 目的探讨高血压前期患者的代谢状态及高敏C反应蛋白(hs-CRP)和分泌型磷脂酶A2(sPLA2)的关系。方法纳入300例体检部及心血管内科门诊初诊者,按照血压水平分为正常血压组(n=81)、高血压前期组(n=153)和高血压组(n=66),分别检测炎症指标sPLA2和hs-CRP;同时观察体重指数(BMI)、空腹血糖(FBG)及血脂[包括总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C)],并分析三组上述指标之间的差异。结果正常血压组、高血压前期组、高血压组hs-CRP和sPLA2水平呈升高趋势,差异均有统计学意义(P<0.05),高血压前期组和高血压组BMI、FBG、TC、TG、LDL-C和HDL-C与正常血压组相比差异有统计学意义(P<0.05)。结论高血压前期及高血压均存在代谢紊乱,且hs-CRPs和sPLA2水平较正常人群升高。 展开更多
关键词 高血压前期 代谢 高敏C反应蛋白 分泌型磷脂酶A 炎症
下载PDF
沙格列汀联合胰岛素治疗对新诊断2型糖尿病患者分泌型磷脂酶A2水平的影响 被引量:2
3
作者 肖婧 徐婉 《中南药学》 CAS 2018年第8期1143-1146,共4页
目的探讨沙格列汀联合胰岛素治疗对新诊断2型糖尿病(T2DM)患者分泌型磷脂酶A2(s PLA2水平的影响。方法选取2013年6月至2017年5月期间在本院内分泌科就诊的新诊断T2DM患者128例作为研究对象,按照入院顺序,根据随机抽签原则分为观察组与... 目的探讨沙格列汀联合胰岛素治疗对新诊断2型糖尿病(T2DM)患者分泌型磷脂酶A2(s PLA2水平的影响。方法选取2013年6月至2017年5月期间在本院内分泌科就诊的新诊断T2DM患者128例作为研究对象,按照入院顺序,根据随机抽签原则分为观察组与对照组各64例,对照组给予胰岛素治疗,观察组在对照组治疗的基础上给予沙格列汀治疗,两组都治疗观察3个月。结果与治疗前相比,观察组与对照组治疗后空腹血糖明显降低(P<0.05),餐后2 h血糖值明显降低(P<0.05);观察组治疗期间的腹泻、恶心、低血糖等不良反应发生率为9.4%,对照组为6.3%,两组对比差异无统计学意义(P>0.05)。与治疗前对比,治疗后两组的Homa-IR明显下降,FINs明显上升(P<0.05);与对照组对比,治疗后观察组的Homa-IR、FINs差异明显(P<0.05)。观察组与对照组治疗后的s PLA2分别为(55.20±11.92)U·mL^(-1)和(64.22±12.84)U·mL^(-1),都明显低于治疗前的(85.22±10.47)U·mL^(-1)和(86.20±13.82)U·mL^(-1)(P<0.05),观察组也明显低于对照组(P<0.05)。结论沙格列汀联合胰岛素治疗新诊断T2DM患者有利于降低s PLA2的表达,能更有效地发挥调节机体胰岛功能,从而促进血糖的降低,安全性也比较好,有很好的应用价值。 展开更多
关键词 沙格列汀 胰岛素 2型糖尿病 分泌型磷脂酶a2
下载PDF
Design, Synthesis, and Biological Evaluation of Novel Dual Inhibitors of Secretory Phospholipase A2 and Sphingomyelin Synthase
4
作者 Xing Gao Haojun Gong +2 位作者 Peng Men Lu Zhou Deyong Ye 《Chinese Journal of Chemistry》 SCIE CAS CSCD 2013年第9期1164-1170,共7页
A novel series of eight SMS and sPLA2 dual inhibitors containing indole and a-amino cyanide fragments of different length and substitution position was synthesized and evaluated by three different in vitro assays. Bio... A novel series of eight SMS and sPLA2 dual inhibitors containing indole and a-amino cyanide fragments of different length and substitution position was synthesized and evaluated by three different in vitro assays. Biological evaluation showed that all compounds provided inhibitory effects against SMS (about 50% inhibition at 100 μmol/L) and sPLA2 (14-32 μmol/L). All the compounds had the SMS activity better than the positive control compound D609 in SMS2 homogenate, with compounds 5b and fie ideal for liver homogenate and SMS2 high expression cell homogenate, respectively. 展开更多
关键词 ATHEROSCLEROSIS secretory phospholipase a2 (sPLa2 sphingomyelin synthase (SMS) multi-targetdrug design dual inhibitors
原文传递
分泌型磷脂酶A_2与环氧合酶-2在早产产妇胎膜中的表达
5
作者 王燕 王少军 《中国妇幼保健》 CAS 北大核心 2012年第22期3494-3497,共4页
目的:探讨分泌型磷脂酶A2(sPLA2)和环氧合酶-2(COX-2)在早产产妇胎膜中的表达及其与早产发生的关系。方法:采用实时荧光定量PCR技术(RT-PCR)检测8例早产产妇(早产临产组)、12例足月临产产妇(足月临产组)和12例足月未临产产妇(对照组)胎... 目的:探讨分泌型磷脂酶A2(sPLA2)和环氧合酶-2(COX-2)在早产产妇胎膜中的表达及其与早产发生的关系。方法:采用实时荧光定量PCR技术(RT-PCR)检测8例早产产妇(早产临产组)、12例足月临产产妇(足月临产组)和12例足月未临产产妇(对照组)胎膜中sPLA2和COX-2 mRNA的表达水平(以目的基因/内参基因×100表示)。结果:sPLA2和COX-2 mRNA在早产临产组胎膜中的表达水平分别为(159.51±38.97)和(144.17±57.31),在足月临产组胎膜中的表达水平分别为(135.07±25.94)和(172.12±66.29),在对照组胎膜中的表达水平分别为(91.03±33.68)和(84.25±42.78)。早产临产组及足月临产组明显高于对照组,差异有统计学意义(P<0.05);早产临产组与足月临产组比较,差异无统计学意义(P>0.05)。3组胎膜中sPLA2和COX-2的表达水平呈正相关,相关系数γ=0.413。结论:sPLA2和COX-2可能参与早产分娩的发动,在早产的发生中起一定作用。 展开更多
关键词 分泌型磷脂酶a2 环氧合酶-2 早产
原文传递
ECMO联合IAPB在急性心源性休克患者急救中的应用价值及对血气状况、预后的影响 被引量:1
6
作者 焦相赟 吴金海 +1 位作者 左远航 杨振坤 《检验医学与临床》 CAS 2023年第21期3156-3159,共4页
目的研究体外膜肺氧合(ECMO)联合主动脉内球囊反搏(IAPB)在急性心源性休克(CS)患者急救中的应用价值及对血气状况、预后的影响。方法根据治疗方案将2019年11月至2020年11月南阳市第一人民医院收治的96例急性CS患者分为对照组(45例)和联... 目的研究体外膜肺氧合(ECMO)联合主动脉内球囊反搏(IAPB)在急性心源性休克(CS)患者急救中的应用价值及对血气状况、预后的影响。方法根据治疗方案将2019年11月至2020年11月南阳市第一人民医院收治的96例急性CS患者分为对照组(45例)和联合组(51例)。对照组给予IAPB,联合组给予ECMO联合IAPB。比较两组病情程度[采用急性生理功能和慢性健康状况评分系统Ⅱ(APACHEⅡ)和多器官功能障碍评分量表(MODS)进行评估],血气指标[血乳酸(Lac)、动脉血氧饱和度(SaO_(2))、pH值]、心功能指标[射血分数(EF)、心脏指数(CI)、每搏输出量(SV)、心输出量(CO)]、其他相关指标[B型脑钠肽(BNP)、心肌肌钙蛋白I(cTnI)、分泌型磷脂酶A2(sPLA2)、可溶性生长刺激表达因子2(sST2)]水平及住院期间病死率。结果治疗后联合组APACHEⅡ、MODS评分均低于对照组(P<0.05);治疗后联合组Lac水平低于对照组,SaO_(2)水平和pH值高于对照组,差异均有统计学意义(P<0.05);治疗后联合组EF及CI、SV、CO水平高于对照组(P<0.05);治疗后,两组血清BNP、cTnI、sPLA2、sST2水平均低于治疗前,且联合组低于对照组,差异均有统计学意义(P<0.05);联合组住院期间病死率[9.80%(5/51)]与对照组[13.33%(6/45)]比较,差异无统计学意义(P>0.05)。结论ECMO联合IAPB可改善CS患者血气相关指标,提高心功能,促进临床症状消退,降低病死风险,减轻炎症反应。 展开更多
关键词 体外膜肺氧合 主动脉内球囊反搏 心源性休克 分泌型磷脂酶a2 可溶性生长刺激表达因子2
下载PDF
Antioxidant,cytotoxic,and anti-venom activity of Alstonia parvifolia Merr.Bark
7
作者 Maria Carmen S.Tan Mary Stephanie S.Carranza +4 位作者 Virgilio C.Linis Raymond S.Malabed Yves Ira A.Reyes Francisco C.Franco,Jr. Glenn G.Oyong 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2021年第10期460-468,共9页
Objective:To evaluate antioxidant,cytotoxic,and anti-venom capacity of crude bark extracts of Alstonia parvifolia Merr.Methods:Gas chromatography-mass spectrometry(GC-MS)and energy dispersive X-ray analyses were accom... Objective:To evaluate antioxidant,cytotoxic,and anti-venom capacity of crude bark extracts of Alstonia parvifolia Merr.Methods:Gas chromatography-mass spectrometry(GC-MS)and energy dispersive X-ray analyses were accomplished to characterize the chemical constituents of Alstonia parvifolia.Biochemical characterization was evaluated using an inhibitory phospholipase A_(2)(PLA_(2))assay,DPPH,and cytotoxicity assays.Using the constituents listed in the GC-MS analyses,molecular docking was conducted to inspect the binding energies between the chosen compounds and selected PLA_(2) isoforms.Results:GC-MS analyses showed that the Alstonia parvifolia crude extract consisted predominantly of acetylmarinobufogenin(14.89%),γ-sitosterol(10.44%),3-O-methyl-D-glucose(5.88%),3,5-dimethoxy-4-hydroxyphenylacetic acid(5.30%),(2α,5α)-17-methoxyaspidofracti­nin-3-one(AFM)(4.08%),and 2,3,5,6,7,8,9-heptahydro-1-phenyl-5-(p-chlorophenylimino)-1H-benzo[e][1,4]thiazepine(HPT)(1.37%).The principal elemental components of Alstonia parvifolia were Ca(4.012%)and K(1.496%),as exhibited by energy dispersive X-ray examination.Alstonia parvifolia showed significant free radical scavenging ability(IC_(50):0.287 mg/mL)and was non-cytotoxic to normal HDFn cells(IC_(50)>100μg/mL).Moreover,Alstonia parvifolia was favorably cytotoxic to MCF-7(IC_(50):4.42µg/mL),followed by H69PR,HT-29,and THP-1,with IC_(50) values of 4.94,5.07,and 6.27µg/mL,respectively.Alstonia parvifolia also displayed notable inhibition against PLA_(2) activity of Naja philippinensis Taylor venom with IC_(50) of(15.2±1.8)μg/mL.Docking and cluster analyses projected negative binding energies from AFM(−6.36 to−9.68 kcal/mol),HPT(−7.38 to−9.77 kcal/mol),and acetylmarinobufogenin(−7.22 to−9.59 kcal/mol).These calculations were for the particular interactions of Alstonia parvifolia constituents to PLA_(2) homologues where the utmost affinity was detected in HPT owing to the dipole interactions with amino acid residues.Conclusions:The bark extract of Alstonia parvifolia shows great potential as an anti-venom agent due to its low cytotoxic profile,remarkable PLA_(2) inhibition,and docking binding energies between its bioactive constituents and PLA_(2) homologues. 展开更多
关键词 Alstonia parvifolia Merr. Naja philippinensis Taylor Gas chromatography-electron ionization-mass spectrometry secretory phospholipase A_(2) Cytotoxicity assay Anti-venom
下载PDF
新诊断2型糖尿病患者血浆脂蛋白相关性磷脂酶A2及分泌型磷脂酶A2水平与动脉粥样硬化的相关研究 被引量:22
8
作者 林秀红 徐明彤 +4 位作者 麦梨芳 唐菊英 王晓艺 李焱 严励 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2016年第6期470-474,共5页
目的观察新诊断2型糖尿病患者血浆脂蛋白相关性磷脂酶A2(LP-PLA2)及分泌型磷脂酶A2(sPLA2)水平,并探讨其临床意义。方法所有受试者均无糖尿病病史,在中山大学孙逸仙纪念医院接受口服葡萄糖耐量试验,分为新诊断2型糖尿病组及血糖正... 目的观察新诊断2型糖尿病患者血浆脂蛋白相关性磷脂酶A2(LP-PLA2)及分泌型磷脂酶A2(sPLA2)水平,并探讨其临床意义。方法所有受试者均无糖尿病病史,在中山大学孙逸仙纪念医院接受口服葡萄糖耐量试验,分为新诊断2型糖尿病组及血糖正常对照组,分别进行人体测量及血糖、胰岛素、血脂谱、LP-PLA2及sPLA2水平检测。结果共纳入90例新诊断2型糖尿病患者及相匹配的58例血糖正常对照者,2型糖尿病组血浆 LP-PLA2水平及 sPLA2水平都显著高于对照组[102.98(76.34,134.31) ng/ml对50.89(23.71,90.40) ng/ml,219.33(130.03,337.330) ng/ml对78.55(75.15,87.02) ng/ml,均P〈0.01],伴动脉粥样硬化病变者升高更显著[133.43(111.54,145.17)ng/ml对99.11(63.02,130.85) ng/ml,235.73(180.48,416.46)ng/ml对182.97(9.08,280.79) ng/ml,均P〈0.05]。相关及回归分析显示血浆LP-PLA2及sPLA2水平均与稳态模型评估的胰岛素抵抗指数呈独立正相关。结论新诊断2型糖尿病患者尤其是伴有动脉粥样硬化者血浆LP-PLA2及sPLA2水平显著升高,并与胰岛素抵抗密切相关。 展开更多
关键词 糖尿病 2 新诊断 脂蛋白相关性磷脂酶a2 分泌型磷脂酶a2
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部